Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 1294 entries
View as:

Injection Site Pain Comparison of Excipient Solutions

Phase: N/A Priority: Normal
NCT ID: NCT04482725 Org: User:
Start: 07/20/20 End: 09/25/20 Due: 09/25/21

Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00659282 Org: User:
Start: 09/11/06 End: 11/15/08 Due: 11/15/09

Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial

Phase: N/A Priority: Normal
NCT ID: NCT00542620 Org: User:
Start: 09/30/07 End: 03/31/09 Due: 03/31/10

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT05021835 Org: User:
Start: 08/30/21 End: 06/26/26 Due: 06/26/27

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

Phase: N/A Priority: Normal
NCT ID: NCT04777409 Org: User:
Start: 05/18/21 End: 10/06/26 Due: 10/06/27

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Phase: N/A Priority: Normal
NCT ID: NCT00755833 Org: User:
Start: 09/30/08 End: 04/30/10 Due: 04/30/11

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00184548 Org: User:
Start: 10/31/05 End: 09/30/08 Due: 09/30/09

A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT05442047 Org: User:
Start: 08/02/22 End: 05/13/25 Due: 05/13/26

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Phase: N/A Priority: Normal
NCT ID: NCT06542536 Org: User:
Start: 08/09/24 End: 10/25/24 Due: 10/25/25

Changing Diabetes® World Tour

Phase: N/A Priority: Normal
NCT ID: NCT01437072 Org: User:
Start: 11/30/10 End: 11/30/11 Due: 11/30/12

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01950650 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02692716 Org: User:
Start: 01/17/17 End: 09/25/18 Due: 09/25/19

An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00700648 Org: User:
Start: 03/31/08 End: 09/30/08 Due: 09/30/09

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

Phase: N/A Priority: Normal
NCT ID: NCT05035095 Org: User:
Start: 09/13/21 End: 05/12/23 Due: 05/12/24

A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01773798 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Awareness, Care & Treatment in Obesity Management (ACTION) Study

Phase: N/A Priority: Normal
NCT ID: NCT03223493 Org: User:
Start: 10/29/15 End: 11/12/15 Due: 11/12/16

An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03786406 Org: User:
Start: 12/03/18 End: 05/31/19 Due: 05/31/20

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Phase: N/A Priority: Normal
NCT ID: NCT00108797 Org: User:
Start: 09/30/01 End: 02/28/06 Due: 02/28/07

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03457012 Org: User:
Start: 03/29/18 End: 12/19/19 Due: 12/19/20

Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00343980 Org: User:
Start: 10/10/06 End: 03/10/08 Due: 03/10/09

Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT04952779 Org: User:
Start: 06/02/21 End: 12/15/24 Due: 12/15/25

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00699179 Org: User:
Start: 06/30/08 End: 09/30/09 Due: 09/30/10

Special Survey of Production of Insulin Aspart Specific Antibody

Phase: N/A Priority: Normal
NCT ID: NCT01487369 Org: User:
Start: 04/30/02 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01165684 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

Phase: N/A Priority: Normal
NCT ID: NCT00922792 Org: User:
Start: 06/30/09 End: 09/30/09 Due: 09/30/10